Simris Alg AB (publ) (SIMRIS-B) - Net Assets
Based on the latest financial reports, Simris Alg AB (publ) (SIMRIS-B) has net assets worth Skr5.49 Million SEK (≈ $590.38K USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr142.46 Million ≈ $15.33 Million USD) and total liabilities (Skr136.97 Million ≈ $14.74 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Simris Alg AB (publ) tangible book value ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr5.49 Million |
| % of Total Assets | 3.85% |
| Annual Growth Rate | N/A |
| 5-Year Change | -102.58% |
| 10-Year Change | -100.72% |
| Growth Volatility | 95.9 |
Simris Alg AB (publ) - Net Assets Trend (2012–2025)
This chart illustrates how Simris Alg AB (publ)'s net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of Simris Alg AB (publ) to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Simris Alg AB (publ) (2012–2025)
The table below shows the annual net assets of Simris Alg AB (publ) from 2012 to 2025. For live valuation and market cap data, see SIMRIS-B stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr-470.00K ≈ $-50.58K |
-108.33% |
| 2024-12-31 | Skr5.64 Million ≈ $607.06K |
-77.98% |
| 2023-12-31 | Skr25.61 Million ≈ $2.76 Million |
+11.20% |
| 2022-12-31 | Skr23.03 Million ≈ $2.48 Million |
+26.41% |
| 2021-12-31 | Skr18.22 Million ≈ $1.96 Million |
-61.58% |
| 2020-12-31 | Skr47.42 Million ≈ $5.10 Million |
+35.51% |
| 2019-12-31 | Skr35.00 Million ≈ $3.77 Million |
-12.03% |
| 2018-12-31 | Skr39.78 Million ≈ $4.28 Million |
-6.80% |
| 2017-12-31 | Skr42.68 Million ≈ $4.59 Million |
-34.66% |
| 2016-12-31 | Skr65.32 Million ≈ $7.03 Million |
+68.87% |
| 2015-12-31 | Skr38.68 Million ≈ $4.16 Million |
+295.64% |
| 2014-12-31 | Skr9.78 Million ≈ $1.05 Million |
+73.65% |
| 2013-12-31 | Skr5.63 Million ≈ $605.92K |
-7.41% |
| 2012-12-31 | Skr6.08 Million ≈ $654.38K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Simris Alg AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 284928400.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr11.12 Million | % |
| Total Equity | Skr-470.00K | 100.00% |
Simris Alg AB (publ) Competitors by Market Cap
The table below lists competitors of Simris Alg AB (publ) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
VIMAB Group AB
ST:VIMAB
|
$13.72 Million |
|
Cocrystal Pharma Inc
NASDAQ:COCP
|
$13.72 Million |
|
Crown Lifters Limited
NSE:CROWN
|
$13.72 Million |
|
Skillful Craftsman Education Tech
NASDAQ:EDTK
|
$13.72 Million |
|
Coast Copper Corp
V:COCO
|
$13.71 Million |
|
Samil Co.Ltd
KQ:032280
|
$13.71 Million |
|
Capital Engineering Network Public Company Limited
BK:CEN
|
$13.70 Million |
|
Nafpaktos Textile Industry S.A
AT:NAYP
|
$13.70 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Simris Alg AB (publ)'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,641,000 to -470,000, a change of -6,111,000 (-108.3%).
- Net loss of 26,811,000 reduced equity.
- New share issuances of 7,496,000 increased equity.
- Other comprehensive income increased equity by 156,730,000.
- Other factors decreased equity by 143,526,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-26.81 Million | -5704.47% |
| Share Issuances | Skr7.50 Million | +1594.89% |
| Other Comprehensive Income | Skr156.73 Million | +33346.81% |
| Other Changes | Skr-143.53 Million | -30537.45% |
| Total Change | Skr- | -108.33% |
Book Value vs Market Value Analysis
This analysis compares Simris Alg AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | Skr398.74 | Skr0.09 | x |
| 2013-12-31 | Skr232.42 | Skr0.09 | x |
| 2014-12-31 | Skr0.68 | Skr0.09 | x |
| 2015-12-31 | Skr2.68 | Skr0.09 | x |
| 2016-12-31 | Skr3.52 | Skr0.09 | x |
| 2017-12-31 | Skr2.11 | Skr0.09 | x |
| 2018-12-31 | Skr1.62 | Skr0.09 | x |
| 2019-12-31 | Skr1.56 | Skr0.09 | x |
| 2020-12-31 | Skr0.43 | Skr0.09 | x |
| 2021-12-31 | Skr0.15 | Skr0.09 | x |
| 2022-12-31 | Skr0.15 | Skr0.09 | x |
| 2023-12-31 | Skr0.11 | Skr0.09 | x |
| 2024-12-31 | Skr0.02 | Skr0.09 | x |
| 2025-12-31 | Skr0.00 | Skr0.09 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Simris Alg AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1660.12%
- • Asset Turnover: 0.01x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-109.26%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -47.11% | -443.85% | 0.10x | 1.10x | Skr-3.47 Million |
| 2013 | -70.16% | -195.51% | 0.32x | 1.12x | Skr-4.51 Million |
| 2014 | -86.44% | -15365.45% | 0.01x | 1.11x | Skr-9.43 Million |
| 2015 | -30.52% | -4172.08% | 0.01x | 1.44x | Skr-15.68 Million |
| 2016 | -29.62% | -2664.20% | 0.01x | 1.17x | Skr-25.88 Million |
| 2017 | -53.83% | -2698.05% | 0.02x | 1.27x | Skr-27.25 Million |
| 2018 | -60.26% | -3146.57% | 0.02x | 1.25x | Skr-27.95 Million |
| 2019 | -76.90% | -1544.06% | 0.03x | 1.49x | Skr-30.41 Million |
| 2020 | -53.99% | -1182.09% | 0.04x | 1.20x | Skr-30.35 Million |
| 2021 | -155.62% | -462.05% | 0.21x | 1.60x | Skr-30.18 Million |
| 2022 | -106.03% | -598.58% | 0.02x | 8.06x | Skr-26.73 Million |
| 2023 | -145.64% | -856.80% | 0.02x | 6.81x | Skr-39.87 Million |
| 2024 | -613.46% | -1197.40% | 0.02x | 27.84x | Skr-35.17 Million |
| 2025 | 0.00% | -1660.12% | 0.01x | 0.00x | Skr-26.76 Million |
Industry Comparison
This section compares Simris Alg AB (publ)'s net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $159,185,570
- Average return on equity (ROE) among peers: -26.34%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Simris Alg AB (publ) (SIMRIS-B) | Skr5.49 Million | -47.11% | 24.97x | $13.71 Million |
| 2cureX AB (2CUREX) | $74.34 Million | -25.47% | 0.06x | $5.16 Million |
| Ascelia Pharma AB (publ) (ACE) | $237.06 Million | -16.83% | 0.06x | $41.03 Million |
| AcouSort AB (ACOU) | $376.48K | 28.69% | 1.44x | $9.52 Million |
| Active Biotech AB (ACTI) | $46.67 Million | -106.88% | 0.22x | $103.60 Million |
| Alzinova AB (ALZ) | $105.53 Million | -12.38% | 0.06x | $8.00 Million |
| AlzeCure Pharma (ALZCUR) | $233.17 Million | -15.43% | 0.02x | $46.62 Million |
| Annexin Pharmaceuticals AB (ANNX) | $15.57 Million | -63.12% | 0.51x | $9.23 Million |
| Alligator Bioscience AB (ATORX) | $41.44 Million | 0.00% | 0.15x | $11.36 Million |
| BioInvent International AB (BINV) | $49.01 Million | -36.81% | 0.66x | $163.58 Million |
| BioArctic AB (publ) (BIOA-B) | $788.68 Million | -15.19% | 0.14x | $2.39 Billion |
About Simris Alg AB (publ)
Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae and cyanobacteria. It also offers cosmetics and skincare products; biopharmaceuticals; and dietary supplements. The company was incorporated in 2011 and is headquartered in Hammen… Read more